Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription
Cell Reports · 2024-03 · 43 (3) · 113816
DOI: 10.1016/j.celrep.2024.113816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-03. Verfasst von Haley M Scott und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenesis and Immunology, Texas A&M Health, College of Medicine, Bryan, TX 77807, USA. Hauptthemen laut MEDLINE: Interferon Type I. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Tight regulation of macrophage immune gene expression is required to fight infection without risking harmful inflammation. The contribution of RNA-binding proteins (RBPs) to shaping the macrophage response to pathogens remains poorly understood. Transcriptomic analysis reveals that a member of the serine/arginine-rich (SR) family of mRNA processing factors, SRSF7, is required for optimal expression of a cohort of interferon-stimulated genes in macrophages. Using genetic and biochemical assays, we discover that in addition to its canonical role in regulating alternative splicing, SRSF7 drives transcription of interferon regulatory transcription factor 7 (IRF7) to promote antiviral immunity. At the Irf7 promoter, SRSF7 maximizes STAT1 transcription factor binding and RNA polymerase II elongation via cooperation with the H4K20me1 histone methyltransferase KMT5a (SET8). These studies define a role for an SR protein in activating transcription and reveal an RBP-chromatin network that orchestrates macrophage antiviral gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Pathogenesis and Immunology, Texas A&M Health, College of Medicine, Bryan, TX 77807, USA.
- Department of Microbial Pathogenesis and Immunology, Texas A&M Health, College of Medicine, Bryan, TX 77807, USA. Electronic address: kpatrick03@tamu.edu.
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Baylor College of Medicine
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Scott, H. M., Smith, M. H., Coleman, A. K., Armijo, K. S., Chapman, M. J., Apostalo, S. L., Wagner, A. R., Watson, R. O., & Patrick, K. L. (2024). Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription. Cell Reports, 43(3), 113816. https://doi.org/10.1016/j.celrep.2024.113816
Vancouver
Scott HM, Smith MH, Coleman AK, Armijo KS, Chapman MJ, Apostalo SL, et al. Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription. Cell Reports. 2024;43(3):113816. doi:10.1016/j.celrep.2024.113816
BibTeX
@article{Scott2024,
author = {Scott, Haley M and Smith, Mackenzie H and Coleman, Aja K and Armijo, Kaitlyn S and Chapman, Morgan J and Apostalo, Summer L and Wagner, Allison R and Watson, Robert O and Patrick, Kristin L},
title = {Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {3},
pages = {113816},
doi = {10.1016/j.celrep.2024.113816}
}
EUVIMED